AA
Ala Alenazi
Investment Manager at Kinnevik
London, England
Overview
Ala Alenazi is currently serving as the VC & Growth at Kinnevik in London, specializing in techbio investments with a background in molecular genetics. With a Ph.D. from the University of Cambridge and experience at notable organizations like Ascension and EIT Health, Ala has excelled in venture capital, life sciences, and healthcare consulting, demonstrating strong leadership and analytical skills in project management and market research.
Work Experience
Investment Manager
2024 - Current
Investing in bio + ai Portfolio: Recursion (Nasdaq: RXRX), Enveda Biosciences
Board Observer
2022 - 2023
Principal, Life Fund
2022 - 2023
Investments: Acurable, Tailor Bio, Kuano, NunaBio, Panakeia, Neuronostics and Aparito (2024, exit to Eli Lilly)
Associate, Life Fund
2021 - 2022
Investments: Novai, Stablepharma, MedAll, ExSeed, Qureight, Veratrak, AMLo Biosciences and NebuFlow Ascension Life Fund is an EIS fund that invests in UK-based Seed+/Series A techbio companies.
Expert Evaluator & Panel (Biotech)
2022 - 2023
Board Observer
2022 - 2023
Board Member
2023 - 2023
Expert - Accelerate@Babraham
2021 - 2023
Board Observer
2022 - 2023
Healthcare Mentor
2021 - 2023
Judge - Libra Programme 2.0
2022 - 2023